SEMA3D and metastatic malignant neoplasm in the lymph nodes: To describe the impact on the prognosis of Sema3D expression in localized ccRCC, we conducted a subgroup analysis by excluding the locally advanced and metastatic patients (T3 grade, lymph node metastasis, and distant metastasis).